George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.85
Bid: 48.60
Ask: 48.70
Change: 1.60 (3.39%)
Spread: 0.10 (0.206%)
Open: 47.55
High: 49.55
Low: 47.55
Prev. Close: 47.25
IPO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

9 Dec 2021 17:47

RNS Number : 1964V
IP Group PLC
09 December 2021
 

IP GROUP plc (the "Company")

 

Transaction in Own Shares

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group"), today announces that Numis Securities Limited purchased on behalf of IP Group the number of ordinary shares of 2 pence each on the London Stock Exchange as set out in the table below (the Repurchased Shares) pursuant to the IP Group share buyback programme announced on 8 October 2021 (the Buyback Programme).

Date of purchase:

09-Dec-21

Number of ordinary shares purchased:

250,000

Highest price paid per ordinary share (GBp):

120.00

Lowest price paid per ordinary share (GBp):

118.20

Volume weighted average price paid per ordinary share (GBp):

119.5266

The Group will hold the Repurchased Shares in treasury. Following the above transaction, the Group holds 19,782,105 of its ordinary shares in treasury and has 1,063,033,287 ordinary shares in issue (including treasury shares). Therefore, the total number of ordinary shares with voting rights will be 1,043,251,182 which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, IP Group under the FCA's Disclosure Guidance and Transparency Rules.

 

IP Group will make further announcements following the completion of any additional purchases pursuant to the Buyback Programme.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the schedule below contains detailed information about the purchases made by Numis Securities Limited on behalf of IP Group as part of the Buyback Programme.

 

Both aggregate data in respect of the Repurchased Shares as well as the individual purchases are set out below.

 

Aggregate information:

 

Issuer name and ISIN: IP Group plc (ISIN: GB00B128J450)

 

Date of purchases:

09 December 2021

Number of ordinary shares purchased:

250,000

Volume weighted average price (pence):

119.5266

Individual transactions:

 

Number of sharespurchased

Transaction price(per share)

Time of transaction

Trading venue

1671

118.20

 08:14:03

LSE

2500

119.60

 09:21:05

LSE

2500

119.60

 09:21:05

LSE

1660

119.60

 09:21:05

LSE

2500

119.60

 09:21:06

LSE

1454

119.60

 09:21:06

LSE

7204

119.40

 09:21:07

LSE

604

119.40

 09:21:07

LSE

7476

120.00

 09:22:53

LSE

556

120.00

 09:22:53

LSE

2800

120.00

 09:22:53

LSE

4557

120.00

 09:23:10

LSE

8061

119.80

 09:24:02

LSE

4049

119.80

 09:39:02

LSE

2900

119.80

 09:39:02

LSE

2972

119.60

 10:03:40

LSE

288

119.60

 10:03:43

LSE

2500

119.60

 10:03:43

LSE

8288

119.60

 10:03:43

LSE

1006

119.60

 10:03:43

LSE

6860

119.40

 10:21:02

LSE

898

119.20

 11:27:11

LSE

3

119.20

 11:27:11

LSE

2510

119.20

 11:28:23

LSE

2500

119.20

 11:28:23

LSE

2500

119.20

 11:43:23

LSE

2930

119.20

 11:51:23

LSE

2500

119.20

 11:51:23

LSE

2500

119.20

 12:01:46

LSE

1649

119.20

 12:10:46

LSE

750

119.20

 12:10:46

LSE

378

119.20

 12:10:46

LSE

2500

119.20

 12:10:46

LSE

1912

119.20

 12:26:23

LSE

379

119.20

 12:32:23

LSE

2500

119.20

 12:32:23

LSE

4802

119.00

 12:40:04

LSE

1910

119.00

 12:40:04

LSE

1216

119.00

 12:40:04

LSE

6696

119.00

 12:40:04

LSE

53

119.40

 12:54:24

LSE

7178

119.40

 12:54:24

LSE

7

119.60

 12:55:23

LSE

26

119.60

 12:58:45

LSE

281

119.60

 13:00:11

LSE

2154

119.60

 13:00:11

LSE

12

119.60

 13:00:11

LSE

3116

119.60

 13:00:11

LSE

1504

119.60

 13:00:11

LSE

1000

119.60

 13:00:11

LSE

158

119.60

 13:00:11

LSE

16

119.60

 13:12:35

LSE

8064

119.60

 13:23:58

LSE

271

119.60

 13:23:58

LSE

5431

119.60

 13:23:58

LSE

2500

119.60

 13:23:58

LSE

7259

119.40

 13:45:03

LSE

2500

119.60

 14:30:12

LSE

2500

119.60

 14:30:12

LSE

1940

119.60

 14:30:12

LSE

2500

119.60

 14:30:12

LSE

6918

119.60

 14:44:12

LSE

1135

119.60

 14:44:12

LSE

1531

119.60

 14:53:10

LSE

2500

119.60

 14:53:10

LSE

2530

119.60

 14:56:10

LSE

301

119.60

 14:56:10

LSE

1645

119.60

 14:56:10

LSE

2500

119.60

 14:56:10

LSE

8161

119.60

 15:18:11

LSE

3400

119.60

 15:25:58

LSE

2500

119.60

 15:25:58

LSE

5202

119.40

 15:28:07

LSE

1723

119.40

 15:28:07

LSE

8321

119.60

 15:45:31

LSE

6060

119.60

 16:17:50

LSE

6904

119.60

 16:17:50

LSE

6813

119.60

 16:17:50

LSE

7729

119.60

 16:17:50

LSE

7826

119.60

 16:17:51

LSE

907

119.60

 16:17:51

LSE

2990

120.00

 16:27:53

LSE

495

120.00

 16:27:53

LSE

 

For more information, please contact:

IP Group plc

www.ipgroupplc.com

Liz Vaughan-Adams, Communications

+44 (0) 20 7444 0062/+44 (0) 7979 853802

Charlotte Street Partners

David Gaffney

+44 (0) 7854 609998

Andrew Wilson

+44 (0) 7810 636995

 

Further information on IP Group is available on our website: www.ipgroupplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSDZMGZNLVGMZM
Date   Source Headline
10th May 202111:15 amRNSInvestor webinars
6th May 20216:13 pmRNSNotice of AGM, Annual Report, Scrip Dividend
6th May 20215:55 pmRNSLTIP & DBSP awards; Director/PDMR shareholding
5th May 20217:00 amRNSPortfolio company Kuur acquired by Athenex
5th May 20217:00 amRNSPortfolio company Inivata acquired by NeoGenomics
4th May 20217:00 amRNSPortfolio company Oxford Nanopore raises £195m
7th Apr 202111:27 amRNSDirector/PDMR Shareholding
31st Mar 20219:15 amRNSHolding(s) in Company
30th Mar 20217:05 amRNSOxford Nanopore announces preparing for IPO in H2
26th Mar 202112:26 pmRNSEMA positive opinion for Diurnal's Chronocort
10th Mar 20217:00 amRNSAnnual Results
4th Mar 20216:07 pmRNSHolding(s) in Company
2nd Mar 202112:03 pmRNSHolding(s) in Company
24th Feb 202110:33 amRNSNotice of Results
18th Feb 20214:31 pmRNSHolding(s) in Company
18th Feb 20218:00 amRNSHolding(s) in Company
17th Feb 20217:00 amRNSPortfolio company ApcinteX acquired by Centessa
10th Feb 20217:00 amRNSIP Group, Inc. raises $50.0m (£36.5m*) of funding
9th Feb 20213:52 pmRNSHolding(s) in Company
2nd Feb 20215:15 pmRNSHolding(s) in Company
11th Jan 20215:29 pmRNSHolding(s) in Company
6th Jan 20214:57 pmRNSPortfolio co Hinge Health completes $300m round
6th Jan 202111:34 amRNSHolding(s) in Company
6th Jan 20217:00 amRNSPortfolio co Oxbotica completes £36m funding round
4th Dec 202011:41 amRNSHolding(s) in Company
3rd Dec 20208:01 amRNSArtios and Merck in global strategic collaboration
25th Nov 20207:00 amRNSDirector Declaration
23rd Nov 20205:05 pmRNSHolding(s) in Company
21st Oct 20207:00 amRNSInvestor webinar
13th Oct 20207:00 amRNSOxford Nanopore funding round and contract win
9th Oct 20209:46 amRNSOxford Nanopore's LamPORE test gains CE-IVD mark
7th Oct 20207:00 amRNSEnterprise Therapeutics' program acquired by Roche
23rd Sep 20201:40 pmRNSHolding(s) in Company
15th Sep 202012:07 pmRNSSecond Price Monitoring Extn
15th Sep 202012:02 pmRNSPrice Monitoring Extension
7th Sep 202012:07 pmRNSSecond Price Monitoring Extn
7th Sep 202012:02 pmRNSPrice Monitoring Extension
1st Sep 20205:18 pmRNSForm 8.3 - Modern Water plc
5th Aug 20207:00 amRNSHalf-yearly results
3rd Aug 20207:00 amRNSNanopore partners with govt on covid-19 test
30th Jul 202012:08 pmRNSSecond Price Monitoring Extn
30th Jul 202012:02 pmRNSPrice Monitoring Extension
29th Jul 20209:45 amRNSHolding(s) in Company
28th Jul 20202:44 pmRNSNotice of Results
14th Jul 20201:29 pmRNSIP Group sells 9.16m shares in Ceres Power
14th Jul 20207:00 amRNSResult of secondary placing in Ceres Power
13th Jul 20205:11 pmRNSProposed secondary placing in Ceres Power Holdings
6th Jul 202012:02 pmRNSPrice Monitoring Extension
6th Jul 20207:00 amRNSAppoints Prof. Clark Chair of ESG Ethics Committee
3rd Jul 202012:07 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.